UCSF home page UCSF home page About UCSF UCSF Medical Center
UCSF navigation bar
UCSF Cardiology
Transforming medicine through innovation and collaboration.
Department of Medicine

Faculty Profiles

Jeffrey Olgin, MD

505 Parnassus Avenue
San Francisco, CA 94117

CLINICAL INTERESTS: Dr. Olgin is a Cardiologist and a Cardiac Electrophysiologist. His main clinical interests include conduction disorders, arrhythmias, catheter ablation, implantable devices—pacemakers and defibrillators, atrial fibrillation, atrial flutter, ventricular tachycardia, sudden death and supraventricular tachycardia.

RESEARCH INTERESTS: Mechanisms of arrhythmias, remodeling and cardiac fibrosis, atrial fibrillation, ventricular fibrillation, sudden death, prediction of atrial fibrillation, prediction of sudden death.
Dr. Olgin's basic research lab is interested in atrial and ventricular remodeling and how these processes occur to develop a substrate for atrial fibrillation and ventricular tachycardia. His work has demonstrated the circuit for human atrial flutter and has demonstrated the importance of atrial fibrosis as a cause for atrial fibrillation. He is currently interested in how TGFß signaling is regulated in the atria to produce atrial fibrosis and atrial fibrillation. His lab is translational in that he utilizes a spectrum of techniques and studies that span from mouse, large animal physiologic models, human tissue, human biomarkers and genetic approaches to understanding the disease. He also has active studies in understanding the remodeling that occurs in the ventricle in the setting of heart failure and myocardial infarction to create the substrate for sudden death and ventricular tachycardia and fibrillation.
Dr. Olgin also runs the UCSF Cardiology Clinical Coordinating Center. He is PI of the VEST study, a multi-center, international randomized study to determine whether a wearable defibrillator vest can reduce the big early sudden death rate post-MI.

Education and Training

Location Degree or Training Specialty Date
University of Pennsylvania M.D. School of Medicine 1989
University of California, San Francisco Clinical Fellowship Internal Medicine
University of California, San Francisco Residency School of Medicine

Related Web Sites

In the News

Recent Articles (143)

Elayi CS, Charnigo RJ, Heron PM, Lee BK, Olgin JE. Primary Prevention of Sudden Cardiac Death Early Post-Myocardial Infarction: Root Cause Analysis for Implantable Cardioverter-Defibrillator Failure and Currently Available Options. Circ Arrhythm Electrophysiol. 2017 Jun; 10(6).

Guo X, Vittinghoff E, Olgin JE, Marcus GM, Pletcher MJ. Volunteer Participation in the Health eHeart Study: A Comparison with the US Population. Sci Rep. 2017 May 16; 7(1):1956.

Nguyen KT, Olgin JE, Pletcher MJ, Ng M, Kaye L, Moturu S, Gladstone RA, Malladi C, Fann AH, Maguire C, Bettencourt L, Christensen MA, Marcus GM. Smartphone-Based Geofencing to Ascertain Hospitalizations. Circ Cardiovasc Qual Outcomes. 2017 Mar; 10(3).

Block VJ, Lizée A, Crabtree-Hartman E, Bevan CJ, Graves JS, Bove R, Green AJ, Nourbakhsh B, Tremblay M, Gourraud PA, Ng MY, Pletcher MJ, Olgin JE, Marcus GM, Allen DD, Cree BA, Gelfand JM. Continuous daily assessment of multiple sclerosis disability using remote step count monitoring. J Neurol. 2016 Nov 28.

Christensen MA, Bettencourt L, Kaye L, Moturu ST, Nguyen KT, Olgin JE, Pletcher MJ, Marcus GM. Direct Measurements of Smartphone Screen-Time: Relationships with Demographics and Sleep. PLoS One. 2016; 11(11):e0165331.

Nguyen KT, Gladstone RA, Dukes JW, Nazer B, Vittinghoff E, Badhwar N, Vedantham V, Gerstenfeld EP, Lee BK, Lee RJ, Tseng ZH, Olgin JE, Scheinman MM, Marcus GM. The QT Interval as a Noninvasive Marker of Atrial Refractoriness. Pacing Clin Electrophysiol. 2016 Oct 18.

Kim AS, Moffatt E, Ursell PC, Devinsky O, Olgin J, Tseng ZH. Sudden neurologic death masquerading as out-of-hospital sudden cardiac death. Neurology. 2016 Oct 18; 87(16):1669-1673.

Lee BK, Olgin JE. The Wearable Cardioverter-Defibrillator: Is It Now the Standard of Care? Circulation. 2016 Aug 30; 134(9):644-6.

Roberts JD, Yang J, Gladstone RA, Longoria J, Whitman IR, Dewland TA, Miller C, Robles A, Poon A, Seiler B, Laframboise WA, Olgin JE, Kwok PY, Marcus GM. Atrial Fibrillation Associated Genetic Variants and Left Atrial Histology: Evaluation for Molecular Sub-Phenotypes. J Cardiovasc Electrophysiol. 2016 Aug 30.

Roberts JD, Hu D, Heckbert SR, Alonso A, Dewland TA, Vittinghoff E, Liu Y, Psaty BM, Olgin JE, Magnani JW, Huntsman S, Burchard EG, Arking DE, Bibbins-Domingo K, Harris TB, Perez MV, Ziv E, Marcus GM. Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals. JAMA Cardiol. 2016 Jul 1; 1(4):442-50.

Dukes JW, Dewland TA, Vittinghoff E, Olgin JE, Pletcher MJ, Hahn JA, Gladstone RA, Marcus GM. Access to alcohol and heart disease among patients in hospital: observational cohort study using differences in alcohol sales laws. BMJ. 2016; 353:i2714.

Brooks GC, Lee BK, Rao R, Lin F, Morin DP, Zweibel SL, Buxton AE, Pletcher MJ, Vittinghoff E, Olgin JE. Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction: The PREDICTS Study. J Am Coll Cardiol. 2016 Mar 15; 67(10):1186-96.

Roberts JD, Dewland TA, Glidden DV, Hoffmann TJ, Arking DE, Chen LY, Psaty BM, Olgin JE, Alonso A, Heckbert SR, Marcus GM. Impact of genetic variants on the upstream efficacy of renin-angiotensin system inhibitors for the prevention of atrial fibrillation. Am Heart J. 2016 May; 175:9-17.

Tanaka Y, Rahmutula D, Duggirala S, Nazer B, Fang Q, Olgin J, Sievers R, Gerstenfeld EP. Diffuse fibrosis leads to a decrease in unipolar voltage: Validation in a swine model of premature ventricular contraction-induced cardiomyopathy. Heart Rhythm. 2016 Feb; 13(2):547-54.

Maltz JS, Tison GH, Alley HF, Budinger TF, Owens CD, Olgin J. Measurement of brachial artery endothelial function using a standard blood pressure cuff. Physiol Meas. 2015 Nov; 36(11):2247-68.

Dixit S, Pletcher MJ, Vittinghoff E, Imburgia K, Maguire C, Whitman IR, Glantz SA, Olgin JE, Marcus GM. Secondhand smoke and atrial fibrillation: Data from the Health eHeart Study. Heart Rhythm. 2016 Jan; 13(1):3-9.

Brooks GC, Vittinghoff E, Iyer S, Tandon D, Kuhar P, Madsen KA, Marcus GM, Pletcher MJ, Olgin JE. Accuracy and Usability of a Self-Administered 6-Minute Walk Test Smartphone Application. Circ Heart Fail. 2015 Sep; 8(5):905-13.

Tseng ZH, Hayward RM, Clark NM, Mulvanny CG, Colburn BJ, Ursell PC, Olgin JE, Hart AP, Moffatt E. Sudden Death in Patients With Cardiac Implantable Electronic Devices. JAMA Intern Med. 2015 Aug; 175(8):1342-50.

Everett TH, Hulley GS, Lee KW, Chang R, Wilson EE, Olgin JE. The effects of remodeling with heart failure on mode of initiation of ventricular fibrillation and its spatiotemporal organization. J Interv Card Electrophysiol. 2015 Sep; 43(3):205-15.

Whitman IR, Pletcher MJ, Vittinghoff E, Imburgia KE, Maguire C, Bettencourt L, Sinha T, Parsnick T, Tison GH, Mulvanny CG, Olgin JE, Marcus GM. Perceptions, Information Sources, and Behavior Regarding Alcohol and Heart Health. Am J Cardiol. 2015 Aug 15; 116(4):642-6.

Yu J, Wu YK, Gu Y, Fang Q, Sievers R, Ding CH, Olgin JE, Lee RJ. Immuno-modification of enhancing stem cells targeting for myocardial repair. J Cell Mol Med. 2015 Jul; 19(7):1483-91.

Van Wagoner DR, Piccini JP, Albert CM, Anderson ME, Benjamin EJ, Brundel B, Califf RM, Calkins H, Chen PS, Chiamvimonvat N, Darbar D, Eckhardt LL, Ellinor PT, Exner DV, Fogel RI, Gillis AM, Healey J, Hohnloser SH, Kamel H, Lathrop DA, Lip GY, Mehra R, Narayan SM, Olgin J, Packer D, Peters NS, Roden DM, Ross HM, Sheldon R, Wehrens XH. Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013. Heart Rhythm. 2015 Jan; 12(1):e5-e29.

Roberts JD, Longoria J, Poon A, Gollob MH, Dewland TA, Kwok PY, Olgin JE, Deo RC, Marcus GM. Targeted deep sequencing reveals no definitive evidence for somatic mosaicism in atrial fibrillation. Circ Cardiovasc Genet. 2015 Feb; 8(1):50-7.

Roberts JD, Dewland TA, Longoria J, Fitzpatrick AL, Ziv E, Hu D, Lin J, Glidden DV, Psaty BM, Burchard EG, Blackburn EH, Olgin JE, Heckbert SR, Marcus GM. Telomere length and the risk of atrial fibrillation: insights into the role of biological versus chronological aging. Circ Arrhythm Electrophysiol. 2014 Dec; 7(6):1026-32.

Hong T, Yang H, Zhang SS, Cho HC, Kalashnikova M, Sun B, Zhang H, Bhargava A, Grabe M, Olgin J, Gorelik J, Marbán E, Jan LY, Shaw RM. Cardiac BIN1 folds T-tubule membrane, controlling ion flux and limiting arrhythmia. Nat Med. 2014 Jun; 20(6):624-32.

Singh DK, Viswanathan MN, Tanel RE, Lee RJ, Lee BK, Marcus GM, Olgin JE, Han F, Vedantham V, Tseng ZH, Pellegrini C, Kawamura M, Gerstenfeld EP, Badhwar N, Scheinman M. His overdrive pacing during supraventricular tachycardia: a novel maneuver for distinguishing atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia. Heart Rhythm. 2014 Aug; 11(8):1327-35.

Woods CE, Olgin J. Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation. Circ Res. 2014 Apr 25; 114(9):1532-46.

Stepanyan G, Badhwar N, Lee RJ, Marcus GM, Lee BK, Tseng ZH, Vedantham V, Olgin J, Scheinman M, Gerstenfeld EP. Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation. J Interv Card Electrophysiol. 2014 Jun; 40(1):33-8.

Kawamura M, Badhwar N, Vedantham V, Tseng ZH, Lee BK, Lee RJ, Marcus GM, Olgin JE, Gerstenfeld EP, Scheinman MM. Coupling interval dispersion and body mass index are independent predictors of idiopathic premature ventricular complex-induced cardiomyopathy. J Cardiovasc Electrophysiol. 2014 Jul; 25(7):756-62.

Goldberger JJ, Basu A, Boineau R, Buxton AE, Cain ME, Canty JM, Chen PS, Chugh SS, Costantini O, Exner DV, Kadish AH, Lee B, Lloyd-Jones D, Moss AJ, Myerburg RJ, Olgin JE, Passman R, Stevenson WG, Tomaselli GF, Zareba W, Zipes DP, Zoloth L. Risk stratification for sudden cardiac death: a plan for the future. Circulation. 2014 Jan 28; 129(4):516-26.

Zhang H, Zhong H, Everett TH, Wilson E, Chang R, Zeng D, Belardinelli L, Olgin JE. Blockade of A2B adenosine receptor reduces left ventricular dysfunction and ventricular arrhythmias 1 week after myocardial infarction in the rat model. Heart Rhythm. 2014 Jan; 11(1):101-9.

Dewland TA, Olgin JE, Vittinghoff E, Marcus GM. Incident atrial fibrillation among Asians, Hispanics, blacks, and whites. Circulation. 2013 Dec 3; 128(23):2470-7.

Hsu JC, Badhwar N, Gerstenfeld EP, Lee RJ, Mandyam MC, Dewland TA, Imburgia KE, Hoffmayer KS, Vedantham V, Lee BK, Tseng ZH, Scheinman MM, Olgin JE, Marcus GM. Randomized trial of conventional transseptal needle versus radiofrequency energy needle puncture for left atrial access (the TRAVERSE-LA study). J Am Heart Assoc. 2013 Oct; 2(5):e000428.

Rahmutula D, Marcus GM, Wilson EE, Ding CH, Xiao Y, Paquet AC, Barbeau R, Barczak AJ, Erle DJ, Olgin JE. Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-ß1. Cardiovasc Res. 2013 Sep 1; 99(4):769-79.

Azadani PN, Soleimanirahbar A, Marcus GM, Haight TJ, Hollenberg M, Olgin JE, Lee BK. Asymptomatic Left Bundle Branch Block Predicts New-Onset Congestive Heart Failure and Death From Cardiovascular Diseases. Cardiol Res. 2012 Dec; 3(6):258-263.

Sung RK, Kim AM, Tseng ZH, Han F, Inada K, Tedrow UB, Viswanathan MN, Badhwar N, Varosy PD, Tanel R, Olgin JE, Stephenson WG, Scheinman M. Diagnosis and ablation of multiform fascicular tachycardia. J Cardiovasc Electrophysiol. 2013 Mar; 24(3):297-304.

Mandyam MC, Vedantham V, Scheinman MM, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Gerstenfeld EP, Olgin JE, Marcus GM. Alcohol and vagal tone as triggers for paroxysmal atrial fibrillation. Am J Cardiol. 2012 Aug 1; 110(3):364-8.

Albert CM, Chen PS, Anderson ME, Cain ME, Fishman GI, Narayan SM, Olgin JE, Spooner PM, Stevenson WG, Van Wagoner DR, Packer DL. Full report from the first annual Heart Rhythm Society Research Forum: a vision for our research future, "dream, discover, develop, deliver". Heart Rhythm. 2011 Dec; 8(12):e1-12.

Hsu JC, Friday J, Lee BK, Azadani PN, Lee RJ, Badhwar N, Tseng ZH, Olgin JE, Marcus GM. Predictors of axillary vein location for vascular access during pacemaker and defibrillator lead implantation. Pacing Clin Electrophysiol. 2011 Dec; 34(12):1585-92.

Aouizerat BE, Vittinghoff E, Musone SL, Pawlikowska L, Kwok PY, Olgin JE, Tseng ZH. GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease. BMC Cardiovasc Disord. 2011; 11:29.

Goldberger JJ, Buxton AE, Cain M, Costantini O, Exner DV, Knight BP, Lloyd-Jones D, Kadish AH, Lee B, Moss A, Myerburg R, Olgin J, Passman R, Rosenbaum D, Stevenson W, Zareba W, Zipes DP. Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks. Circulation. 2011 May 31; 123(21):2423-30.

Hoffmayer KS, Yang Y, Joseph S, McCabe JM, Bhave P, Hsu J, Ng RK, Lee BK, Badhwar N, Lee RJ, Tseng ZH, Olgin JE, Narayan SM, Marcus GM, Scheinman MM. Predictors of unusual ECG characteristics in cavotricuspid isthmus-dependent atrial flutter ablation. Pacing Clin Electrophysiol. 2011 Oct; 34(10):1251-7.

Iwai S, Badhwar N, Markowitz SM, Stambler BS, Keung E, Lee RJ, Chung JH, Olgin JE, Scheinman MM, Lerman BB. Electrophysiologic properties of para-Hisian atrial tachycardia. Heart Rhythm. 2011 Aug; 8(8):1245-53.

Azadani PN, Kumar UN, Yang Y, Scheinman MM, Hoopes CW, Marcus GM, Rifkin C, Olgin JE, Lee BK. Frequency of atrial flutter after adult lung transplantation. Am J Cardiol. 2011 Mar 15; 107(6):922-6.

Olgin JE. Approach to the Patient with Suspected Arrhythmias. Cecil's Textbook of Medicine, 24th Edition. Eds Ausiello D, Goldman L. 2011.

Nguyen DT, Scheinman M, Olgin J, Badhwar N. Wenckebach during supraventricular tachycardia. Circ Arrhythm Electrophysiol. 2010 Dec; 3(6):671-3.

Yang Y, Varma N, Badhwar N, Tanel RE, Sundara S, Lee RJ, Lee BK, Tseng ZH, Marcus GM, Kim AM, Olgin JE, Scheinman MM. Prospective observations in the clinical and electrophysiological characteristics of intra-isthmus reentry. J Cardiovasc Electrophysiol. 2010 Oct; 21(10):1099-106.

Chi NC, Bussen M, Brand-Arzamendi K, Ding C, Olgin JE, Shaw RM, Martin GR, Stainier DY. Cardiac conduction is required to preserve cardiac chamber morphology. Proc Natl Acad Sci U S A. 2010 Aug 17; 107(33):14662-7.

Nguyen DT, Ding C, Wilson E, Marcus GM, Olgin JE. Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias. Heart Rhythm. 2010 Oct; 7(10):1438-45.

Marcus GM, Olgin JE, Whooley M, Vittinghoff E, Stone KL, Mehra R, Hulley SB, Schiller NB. Racial differences in atrial fibrillation prevalence and left atrial size. Am J Med. 2010 Apr; 123(4):375.e1-7.

Ding C, Gepstein L, Nguyen DT, Wilson E, Hulley G, Beaser A, Lee RJ, Olgin J. High-resolution optical mapping of ventricular tachycardia in rats with chronic myocardial infarction. Pacing Clin Electrophysiol. 2010 Jun 1; 33(6):687-95.

Everett TH, Wilson EE, Hulley GS, Olgin JE. Transmural characteristics of atrial fibrillation in canine models of structural and electrical atrial remodeling assessed by simultaneous epicardial and endocardial mapping. Heart Rhythm. 2010 Apr; 7(4):506-17.

Olgin JE, Zipes DP. Specific Arrhythmias: Diagnosis and Treatment. In: Heart Disease: A Textbook of Cardiovascular Medicine. 9th Ed. Edited by Braunwald, Zipes, Libby. 2010.

Everett T, Olgin JE. Atrial Fibrillation Substrates and Mechanisms. In Cardiac Electrophysiology. 5th Ed. Edited by Zipes and Jalife. 2010.

Marcus GM, Smith LM, Ordovas K, Scheinman MM, Kim AM, Badhwar N, Lee RJ, Tseng ZH, Lee BK, Olgin JE. Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm. 2010; 7(2):149-54.

Hsu JC, Tanel RE, Lee BK, Scheinman MM, Badhwar N, Lee RJ, Tseng ZH, Olgin JE, Marcus GM. Differences in accessory pathway location by sex and race. Heart Rhythm. 2010 Jan; 7(1):52-6.

Tseng ZH, Vittinghoff E, Musone SL, Lin F, Whiteman D, Pawlikowska L, Kwok PY, Olgin JE, Aouizerat BE. Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm. 2009 Dec; 6(12):1745-50.

Sakhuja R, Smith LM, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Scheinman MM, Olgin JE, Marcus GM. Test characteristics of neck fullness and witnessed neck pulsations in the diagnosis of typical AV nodal reentrant tachycardia. Clin Cardiol. 2009 Aug; 32(8):E13-8.

Kim AM, Olgin JE. Microfibrosis and complex fractionated atrial electrograms. Heart Rhythm. 2009 Jun; 6(6):811-2.

Kim AM, Olgin JE, Everett TH. Role of atrial substrate and spatiotemporal organization in atrial fibrillation. Heart Rhythm. 2009 Aug; 6(8 Suppl):S1-7.

Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar D, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie BM, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TS, Van Wagoner DR, Waldo AL, Wyse DG. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation. 2009 Feb 3; 119(4):606-18.

Badwhar N, Lee B, Olgin JE. Atrial Tachycardias. In Cardiac Mapping. Edited by Shenasa and Bogreffe. 2009.

Kim AM, Turakhia M, Lu J, Badhwar N, Lee BK, Lee RJ, Marcus GM, Tseng ZH, Scheinman M, Olgin JE. Impact of remote magnetic catheter navigation on ablation fluoroscopy and procedure time. Pacing Clin Electrophysiol. 2008 Nov; 31(11):1399-404.

Turakhia M, Prasad M, Olgin J, Badhwar N, Tseng ZH, Lee R, Marcus GM, Lee BK. Rates and severity of perforation from implantable cardioverter-defibrillator leads: a 4-year study. J Interv Card Electrophysiol. 2009 Jan; 24(1):47-52.

Pellegrini CN, Lee K, Olgin JE, Turakhia MP, Tseng ZH, Lee R, Badhwar N, Lee B, Varosy PD. Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace. 2008 Nov; 10(11):1296-301.

Everett TH, Lee KW, Wilson EE, Guerra JM, Varosy PD, Olgin JE. Safety profiles and lesion size of different radiofrequency ablation technologies: a comparison of large tip, open and closed irrigation catheters. J Cardiovasc Electrophysiol. 2009 Mar; 20(3):325-35.

McCabe JM, Smith LM, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Scheinman MM, Olgin JE, Marcus GM. Protracted CRP elevation after atrial fibrillation ablation. Pacing Clin Electrophysiol. 2008 Sep; 31(9):1146-51.

Marcus GM, Olgin JE. Preventing atrial fibrillation after cardiac surgery: a new method using an old tool. Circulation. 2008 Jul 29; 118(5):467-8.

Tseng ZH, Aouizerat BE, Pawlikowska L, Vittinghoff E, Lin F, Whiteman D, Poon A, Herrington D, Howard TD, Varosy PD, Hulley SB, Malloy M, Kane J, Kwok PY, Olgin JE. Common beta-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease. Heart Rhythm. 2008 Jun; 5(6):814-21.

Pellegrini CN, Yeh RW, Olgin J, Lee BK. Episodic ventricular pacing with intact atrioventricular nodal function in a DDDR device: what is the rhythm and how can it be prevented? Heart Rhythm. 2008 Jun; 5(6):897-8.

Marcus GM, Smith LM, Whiteman D, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Scheinman MM, Olgin JE. Alcohol intake is significantly associated with atrial flutter in patients under 60 years of age and a shorter right atrial effective refractory period. Pacing Clin Electrophysiol. 2008 Mar; 31(3):266-72.

Marcus GM, Smith LM, Vittinghoff E, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Scheinman MM, Olgin JE. A first-degree family history in lone atrial fibrillation patients. Heart Rhythm. 2008 Jun; 5(6):826-30.

Everett TH, Byrd I, Wilson E, Skoglund J, Olgin J. Phase angle shift is a better determinant for catheter electrode contact with tissue compared to a catheter sensed electrogram. Conf Proc IEEE Eng Med Biol Soc. 2008; 2008:1733-6.

Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE. Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J. 2008 Feb; 155(2):303-9.

Marcus GM, Smith LM, Glidden DV, Wilson E, McCabe JM, Whiteman D, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Scheinman MM, Olgin JE. Markers of inflammation before and after curative ablation of atrial flutter. Heart Rhythm. 2008 Feb; 5(2):215-21.

Everett TH, Wilson EE, Olgin JE. Effects of atrial fibrillation substrate and spatiotemporal organization on atrial defibrillation thresholds. Heart Rhythm. 2007 Aug; 4(8):1048-56.

Turakhia MP, Varosy PD, Lee K, Tseng ZH, Lee R, Badhwar N, Scheinman M, Lee BK, Olgin JE. Impact of renal function on survival in patients with implantable cardioverter-defibrillators. Pacing Clin Electrophysiol. 2007 Mar; 30(3):377-84.

Everett TH, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm. 2007 Mar; 4(3 Suppl):S24-7.

Marcus GM, Ren X, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Foster E, Olgin JE. Repeat transseptal catheterization after ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2007 Jan; 18(1):55-9.

Marcus GM, Yang Y, Varosy PD, Ordovas K, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Scheinman MM, Olgin JE. Regional left atrial voltage in patients with atrial fibrillation. Heart Rhythm. 2007 Feb; 4(2):138-44.

Lee KW, Everett TH, Rahmutula D, Guerra JM, Wilson E, Ding C, Olgin JE. Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation. 2006 Oct 17; 114(16):1703-12.

Everett TH, Wilson EE, Verheule S, Guerra JM, Foreman S, Olgin JE. Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling. Am J Physiol Heart Circ Physiol. 2006 Dec; 291(6):H2911-23.

Guerra JM, Everett TH, Lee KW, Wilson E, Olgin JE. Effects of the gap junction modifier rotigaptide (ZP123) on atrial conduction and vulnerability to atrial fibrillation. Circulation. 2006 Jul 11; 114(2):110-8.

Everett TH, Wilson EE, Foreman S, Olgin JE. Mechanisms of ventricular fibrillation in canine models of congestive heart failure and ischemia assessed by in vivo noncontact mapping. Circulation. 2005 Sep 13; 112(11):1532-41.

O'Connell JW, Schreck C, Moles M, Badwar N, DeMarco T, Olgin J, Lee B, Tseng Z, Kumar U, Botvinick EH. A unique method by which to quantitate synchrony with equilibrium radionuclide angiography. J Nucl Cardiol. 2005 Jul-Aug; 12(4):441-50.

Adamson PB, Barr RC, Callans DJ, Chen PS, Lathrop DA, Makielski JC, Nerbonne JM, Nuss HB, Olgin JE, Przywara DA, Rosen MR, Rozanski GJ, Spach MS, Yamada KA. The perplexing complexity of cardiac arrhythmias: beyond electrical remodeling. Heart Rhythm. 2005 Jun; 2(6):650-9.

Murray KT, Rottman JN, Arbogast PG, Shemanski L, Primm RK, Campbell WB, Solomon AJ, Olgin JE, Wilson MJ, Dimarco JP, Beckman KJ, Dennish G, Naccarelli GV, Ray WA. Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm. 2004 Dec; 1(6):669-75.

Verheule S, Sato T, Everett T, Engle SK, Otten D, Rubart-von der Lohe M, Nakajima HO, Nakajima H, Field LJ, Olgin JE. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res. 2004 Jun 11; 94(11):1458-65.

Verheule S, Wilson E, Banthia S, Everett TH, Shanbhag S, Sih HJ, Olgin J. Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation. Am J Physiol Heart Circ Physiol. 2004 Aug; 287(2):H634-44.

Everett TH, Verheule S, Wilson EE, Foreman S, Olgin JE. Left atrial dilatation resulting from chronic mitral regurgitation decreases spatiotemporal organization of atrial fibrillation in left atrium. Am J Physiol Heart Circ Physiol. 2004 Jun; 286(6):H2452-60.

Everett TH, Olgin JE. Basic mechanisms of atrial fibrillation. Cardiol Clin. 2004 Feb; 22(1):9-20.

Lee KW, Everett TH, Tolga Ilhan H, Linscott I, Olgin JE. Feature extraction of the atrial fibrillation signal using the continuous wavelet transform. Conf Proc IEEE Eng Med Biol Soc. 2004; 1:275-8.

Miller JM, Olgin JE, Das MK. Atrial fibrillation: what are the targets for intervention? J Interv Card Electrophysiol. 2003 Oct; 9(2):249-57.

Verheule S, Wilson E, Everett T, Shanbhag S, Golden C, Olgin J. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation. 2003 May 27; 107(20):2615-22.

Arora R, Verheule S, Scott L, Navarrete A, Katari V, Wilson E, Vaz D, Olgin JE. Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation. 2003 Apr 8; 107(13):1816-21.

Verheule S, Wilson EE, Arora R, Engle SK, Scott LR, Olgin JE. Tissue structure and connexin expression of canine pulmonary veins. Cardiovasc Res. 2002 Sep; 55(4):727-38.

Alberte C, Hadian D, Miller JM, Olgin JE. A changing tachycardia that did not change. J Cardiovasc Electrophysiol. 2002 Jul; 13(7):727-9.

Page RL, Kerber RE, Russell JK, Trouton T, Waktare J, Gallik D, Olgin JE, Ricard P, Dalzell GW, Reddy R, Lazzara R, Lee K, Carlson M, Halperin B, Bardy GH. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol. 2002 Jun 19; 39(12):1956-63.

Hadian D, Zipes DP, Olgin JE, Miller JM. Short-term rapid atrial pacing produces electrical remodeling of sinus node function in humans. J Cardiovasc Electrophysiol. 2002 Jun; 13(6):584-6.

Olgin JE, Takahashi T, Wilson E, Vereckei A, Steinberg H, Zipes DP. Effects of thoracic spinal cord stimulation on cardiac autonomic regulation of the sinus and atrioventricular nodes. J Cardiovasc Electrophysiol. 2002 May; 13(5):475-81.

Olgin JE, Verheule S. Transgenic and knockout mouse models of atrial arrhythmias. Cardiovasc Res. 2002 May; 54(2):280-6.

Viskin S, Halkin A, Olgin JE. Treatable causes of sudden death: not really "treatable" or not really the cause? J Am Coll Cardiol. 2001 Nov 15; 38(6):1725-7.

Darbar D, Olgin JE, Miller JM, Friedman PA. Localization of the origin of arrhythmias for ablation: from Electrocardiography to advanced endocardial mapping systems. J Cardiovasc Electrophysiol. 2001 Nov; 12(11):1309-25.

Wu J, Wu J, Olgin J, Miller JM, Zipes DP. Mechanisms underlying the reentrant circuit of atrioventricular nodal reentrant tachycardia in isolated canine atrioventricular nodal preparation using optical mapping. Circ Res. 2001 Jun 8; 88(11):1189-95.

Olgin JE. Is the coronary sinus really reflective of left atrial activation? J Cardiovasc Electrophysiol. 2001 Jun; 12(6):629.

Scott LR, Hadian D, Olgin JE, Miller JM. Termination of reentrant atrial tachycardia by a nonpropagated extrastimulus. J Cardiovasc Electrophysiol. 2001 Mar; 12(3):388.

Altemose GT, Zipes DP, Weksler J, Miller JM, Olgin JE. Inhibition of the Na(+)/H(+) exchanger delays the development of rapid pacing-induced atrial contractile dysfunction. Circulation. 2001 Feb 6; 103(5):762-8.

Sih HJ, Zipes DP, Berbari EJ, Adams DE, Olgin JE. Differences in organization between acute and chronic atrial fibrillation in dogs. J Am Coll Cardiol. 2000 Sep; 36(3):924-31.

Jayachandran JV, Zipes DP, Weksler J, Olgin JE. Role of the Na(+)/H(+) exchanger in short-term atrial electrophysiological remodeling. Circulation. 2000 Apr 18; 101(15):1861-6.

Jayachandran JV, Sih HJ, Winkle W, Zipes DP, Hutchins GD, Olgin JE. Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation. 2000 Mar 14; 101(10):1185-91.

Sih HJ, Zipes DP, Berbari EJ, Olgin JE. A high-temporal resolution algorithm for quantifying organization during atrial fibrillation. IEEE Trans Biomed Eng. 1999 Apr; 46(4):440-50.

Olgin JE, Viskin S. Management of intermittent atrial fibrillation: drugs to maintain sinus rhythm. J Cardiovasc Electrophysiol. 1999 Mar; 10(3):433-41.

Miller JM, Jayachandran JV, Coppess MA, Olgin JE. Optimal management of the patient with chronic atrial fibrillation: whom to cardiovert? J Cardiovasc Electrophysiol. 1999 Mar; 10(3):442-9.

Miller JM, Engelstein ED, Groh WJ, Olgin JE, al-Sheikh T, Altemose GT. Radiofrequency catheter ablation for postinfarct ventricular tachycardia. Curr Opin Cardiol. 1999 Jan; 14(1):30-5.

Olgin JE, Sih HJ, Hanish S, Jayachandran JV, Wu J, Zheng QH, Winkle W, Mulholland GK, Zipes DP, Hutchins G. Heterogeneous atrial denervation creates substrate for sustained atrial fibrillation. Circulation. 1998 Dec 8; 98(23):2608-14.

Olgin JE, Jayachandran JV, Engesstein E, Groh W, Zipes DP. Atrial macroreentry involving the myocardium of the coronary sinus: a unique mechanism for atypical flutter. J Cardiovasc Electrophysiol. 1998 Oct; 9(10):1094-9.

Kalman JM, Olgin JE, Karch MR, Hamdan M, Lee RJ, Lesh MD. "Cristal tachycardias": origin of right atrial tachycardias from the crista terminalis identified by intracardiac echocardiography. J Am Coll Cardiol. 1998 Feb; 31(2):451-9.

Saxon LA, Kerwin WF, Cahalan MK, Kalman JM, Olgin JE, Foster E, Schiller NB, Shinbane JS, Lesh MD, Merrick SH. Acute effects of intraoperative multisite ventricular pacing on left ventricular function and activation/contraction sequence in patients with depressed ventricular function. J Cardiovasc Electrophysiol. 1998 Jan; 9(1):13-21.

Olgin JE, Lesh M, Kalman J. Electrical mapping in combination with intracardiac ultrasound for electrical-anatomic correlation. J Electrocardiol. 1998; 30 Suppl:6-10.

Olgin JE, Sih HJ. Ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 1997 Nov; 8(11):1266-8.

Olgin JE, Lesh MD. The laboratory evaluation and role of catheter ablation for patients with atrial flutter. Cardiol Clin. 1997 Nov; 15(4):677-88.

Olgin JE, Kalman JM, Chin M, Stillson C, Maguire M, Ursel P, Lesh MD. Electrophysiological effects of long, linear atrial lesions placed under intracardiac ultrasound guidance. Circulation. 1997 Oct 21; 96(8):2715-21.

Kalman JM, Olgin JE, Karch MR, Lesh MD. Use of intracardiac echocardiography in interventional electrophysiology. Pacing Clin Electrophysiol. 1997 Sep; 20(9 Pt 1):2248-62.

Kalman JM, Olgin JE, Saxon LA, Lee RJ, Scheinman MM, Lesh MD. Electrocardiographic and electrophysiologic characterization of atypical atrial flutter in man: use of activation and entrainment mapping and implications for catheter ablation. J Cardiovasc Electrophysiol. 1997 Feb; 8(2):121-44.

Olgin JE, Kalman JM, Saxon LA, Lee RJ, Lesh MD. Mechanism of initiation of atrial flutter in humans: site of unidirectional block and direction of rotation. J Am Coll Cardiol. 1997 Feb; 29(2):376-84.

Viskin S, Barron HV, Heller K, Scheinman MM, Olgin JE. The treatment of atrial fibrillation: pharmacologic and nonpharmacologic strategies. Curr Probl Cardiol. 1997 Feb; 22(2):37-108.

Kalman JM, Fitzpatrick AP, Olgin JE, Chin MC, Lee RJ, Scheinman MM, Lesh MD. Biophysical characteristics of radiofrequency lesion formation in vivo: dynamics of catheter tip-tissue contact evaluated by intracardiac echocardiography. Am Heart J. 1997 Jan; 133(1):8-18.

Viskin S, Heller K, Barron HV, Kitzis I, Hamdan M, Olgin JE, Wong MJ, Grant SE, Lesh MD. Postextrasystolic U wave augmentation, a new marker of increased arrhythmic risk in patients without the long QT syndrome. J Am Coll Cardiol. 1996 Dec; 28(7):1746-52.

Olgin JE, Kalman JM, Lesh MD. Conduction barriers in human atrial flutter: correlation of electrophysiology and anatomy. J Cardiovasc Electrophysiol. 1996 Nov; 7(11):1112-26.

kalman JM, Olgin JE, Karch MR, Lesh MD. Regional entrainment of atrial fibrillation in man. J Cardiovasc Electrophysiol. 1996 Sep; 7(9):867-76.

Kalman JM, Olgin JE, Saxon LA, Fisher WG, Lee RJ, Lesh MD. Activation and entrainment mapping defines the tricuspid annulus as the anterior barrier in typical atrial flutter. Circulation. 1996 Aug 1; 94(3):398-406.

Olgin JE, Ursell P, Kao AK, Lesh MD. Pathological findings following slow pathway ablation for AV nodal reentrant tachycardia. J Cardiovasc Electrophysiol. 1996 Jul; 7(7):625-31.

Saxon LA, Kalman JM, Olgin JE, Scheinman MM, Lee RJ, Lesh MD. Results of radiofrequency catheter ablation for atrial flutter. Am J Cardiol. 1996 May 1; 77(11):1014-6.

Lesh MD, Kalman JM, Olgin JE. New approaches to treatment of atrial flutter and tachycardia. J Cardiovasc Electrophysiol. 1996 Apr; 7(4):368-81.

Kalman JM, VanHare GF, Olgin JE, Saxon LA, Stark SI, Lesh MD. Ablation of 'incisional' reentrant atrial tachycardia complicating surgery for congenital heart disease. Use of entrainment to define a critical isthmus of conduction. Circulation. 1996 Feb 1; 93(3):502-12.

Lesh MD, Kalman JM, Olgin JE, Ellis WS. The role of atrial anatomy in clinical atrial arrhythmias. J Electrocardiol. 1996; 29 Suppl:101-13.

Lee RJ, Kalman JM, Fitzpatrick AP, Epstein LM, Fisher WG, Olgin JE, Lesh MD, Scheinman MM. Radiofrequency catheter modification of the sinus node for "inappropriate" sinus tachycardia. Circulation. 1995 Nov 15; 92(10):2919-28.

Olgin JE, Kalman JM, Fitzpatrick AP, Lesh MD. Role of right atrial endocardial structures as barriers to conduction during human type I atrial flutter. Activation and entrainment mapping guided by intracardiac echocardiography. Circulation. 1995 Oct 1; 92(7):1839-48.

Olgin JE, Scheinman MM. Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction. J Am Coll Cardiol. 1993 Mar 1; 21(3):557-64.

Olgin J, Rosenberg H, Allen G, Seestedt R, Chance B. A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility. Anesth Analg. 1991 Jan; 72(1):36-47.

Olgin J, Argov Z, Rosenberg H, Tuchler M, Chance B. Non-invasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy. Anesthesiology. 1988 Apr; 68(4):507-13.

Olgin J, Connett RJ, Chance B. Mitochondrial redox changes during rest-work transition in dog gracilis muscle. Adv Exp Med Biol. 1986; 200:545-54.

  Select data provided by UCSF Profiles, powered by CTSI at UCSF. Learn more about the data source.